CoChat

Prolonged treatment with topical glucocorticoids results in an inhibition of the allergen‐induced weal‐and‐flare response and a reduction in skin mast cell numbers and histamine content

PIPKORN, U., HAMMARLUND, A., ENERBÄCK, L. · 1989 · Clinical & Experimental Allergy
Cited by 87

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Summary: The inhibitory effects of topical glucocorticosteroid treatment on the immediate dermal allergic reaction were studied in 10 patients in a double, randomized, placebo‐controlled fashion. The aim was to study whether a prolongation of the treatment time would enhance the inhibitory effect beyond the 30–40% reduction previously reported after I week of treatment, and whether any changes in skin reactivity were accompanied by changes in the level of mast cells or histamine at the challenge site. Allergen and histamine skin‐prick tests were performed on both forearms before the start of the study and after 2 and 4 weeks of treatment with placebo cream on one forearm and with 0.05% clobetasot‐17‐propionate cream on the other. Punch biopsies from the skin treated actively and with placebo were taken after 4 weeks in eight of the patients. The specimens were used for the light‐microscopic evaluation of mast cell density and for the measurement of histamine and protein content. After 4 weeks of treatment we found a reduction in the allergen‐induced weal (72%; P<0.001) and flare (62%; P<0.05) response. There was also a minor reduction in the histamine‐induced weal (38%; P<0.05) but not the flare response, suggesting that the glucocorticoid treatment induced a reduced mediator release at allergen challenge. This could be partially explained by the finding of a reduction in the number of detectable skin mast cells (85%; from 0.78 to 0.11 mast cells per unit area) and in the histamine content of the skin as related to the tissue wet weight (36%; P<0.05). There was also an increase in the protein content of the skin in relation to tissue weight (37%; P<0.05), which was presumably partly caused by a reduction in the water content of the skin, further enhancing the reduction of histamine when related to tissue protein content to 56% (P<0.01). These findings of a glucocorticosteroid induced reduction in the mast cell density of the skin differ from the results of our previous study of airway mucosa, where the mast cell density was not reduced by topical glucocorticoid treatment in a dosage which effectively inhibits the immediate allergic response after allergen challenge. These differences can be interpreted as being due to differences in the steroid responsiveness of different mast cell populations, but may also depend on differences in the pharmacokinetics of the glucocorticosteroids when applied locally to the skin as opposed to the airway mucosa. The present results emphasize the role of the mast cell and histamine in the pathogenesis of the immediate dermal allergic reaction, but also stress that the effects of glucocorticosteroids are largely dependent not only on dosage but also on treatment times. Results from in‐vitro and other studies involving short‐term treatment with glucocorticosteroids should therefore be interpreted with caution.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2222.1989.tb02338.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 87

Metadata

Authors
PIPKORN, U., HAMMARLUND, A., & ENERBÄCK, L.
Venue
Clinical & Experimental Allergy
Publisher
Wiley
Published
1989-01
Volume
19
Issue
1
Pages
19-25
ISSN
  • 0954-7894 (ISSN-L)
  • 1365-2222
OpenAlex
W1993287709
Cited by
87
References
1
FWCI
1.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prolonged treatment with topical glucocorticoids results in an inhibition of the allergen‐induced weal‐and‐flare response and a reduction in skin mast cell numbers and histamine content. https://app.cochat.ai/papers/10.1111/j.1365-2222.1989.tb02338.x
The paper
PIPKORN, U., HAMMARLUND, A., & ENERBÄCK, L. (1989). Prolonged treatment with topical glucocorticoids results in an inhibition of the allergen‐induced weal‐and‐flare response and a reduction in skin mast cell numbers and histamine content. Clinical & Experimental Allergy. https://doi.org/10.1111/j.1365-2222.1989.tb02338.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.